5 April, 2024
PSYCH CAPITAL
PLC
("Psych
Capital", or "the Company")
William Potts Board
Resignation and Role Change to Strategic Adviser
Share Options
Grant
London, UK, 5 April 2024 - Psych
Capital Plc, an investment firm focused on innovative
drug-development in the field of mental health, announces that
William Potts, Chief Investment Officer, has stepped down from his
role as a director of the Company. William Potts will remain as a
Strategic Adviser of the Company. In his role as Strategic Adviser,
William will assist with strategic opportunities for the
Company.
William Potts commented: "It has
been a pleasure to have worked with the exceptional team at Psych
Capital over the years and I would like to thank them all for their
hard work and dedication. I look forward to supporting Psych
Capital during this exciting time to become a leader in Psychedelic
science and healthcare."
Rivki Stern, Chief Executive Officer
of the Company, stated: "William Potts has been instrumental in the
building of Psych Capital and the implementation of its strategy
and value proposition. We will continue to rely on William's
strategic advice as we reaffirm our Company's commitment to
supporting and developing pivotal treatments for mental
health."
Grant of Share Options
The Company further announces that
it has granted share options over ordinary shares of the Company,
as part of the unapproved share option scheme, to its former
chairman, Joseph Colliver, in recognition for the uncompensated
work done by him leading up to the acquisition of Shortwave Pharma
Inc,. The options grant was decided upon at the time of completion
of the acquisition in November last year.
50,000 share options will be granted
under the existing share option scheme with effect from 4 April
2024 and will be capable of being exercised for a period of 2
years. The exercise price is 2.95 pence per share, the mid-market
share price on the day of issue, being April 4, 2024.
The directors of the Company accept
responsibility for the contents of this announcement.
Enquiries:
Company:
Rivki Stern: +972 54 762
1621
info@psych.capital
https://psych.capital
Peterhouse Capital Limited:
Corporate Adviser:
Guy
Miller /Narisha Ragoonanthun: + 44 (0) 20 7469 0930
Corporate Broker
Lucy Williams: +44 (0) 20 7469
0930
Duncan Vasey: +44 (0) 20 7220 9797 (Direct)
